Teva
Fierce local opposition to Teva’s restructure efforts
December 15, 2017Manufacturing and Production, Medical Communications Teva, biotech, drugs, pharma, pharmaceutical
When Kare Shultz decided to take on the CEO position at Teva he would have known that he was setting …
Tumultuous times at Teva continue, with Chairman exit
December 13, 2017Medical Communications, Research and Development Teva, biotech, drugs, pharma, pharmaceutical
In the latest addition to a number of high profile exits from Teva, previous interim Chief Executive and the company’s …
Teva job cut rumours resurface, 10,000 expected
December 11, 2017Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical
Only last month, the story broke that Teva was looking to cut away a number of employees, the rumours have …
Teva looks set to axe thousands of positions and a big name
November 23, 2017Manufacturing and Production Teva, biotech, drugs, pharma, pharmaceutical
Teva’s troubled year needs little detailing, those following the company have seen it lurch from one piece of bad news …
Teva’s woes continue, as shares sink to 17-year low on Q3 results
November 2, 2017Medical Communications Mylan, Teva, biotech, drugs, pharma, pharmaceutical
Spare a thought for Kare Schultz, he agreed to take on the position of CEO at Teva at the start …
Allergan ready to take a loss by selling Teva shares
November 2, 2017Sales and Marketing Allergan, Mylan, Teva, biotech, drugs, pharma, pharmaceutical
Allergan sold its generic business to Teva back in August 2016 for a sum of $33 billion and 100 million …
CEO and President implicated as price-fixing probe widens
November 1, 2017Research and Development, Sales and Marketing Mylan, Teva, biotech, drugs, pharma, pharmaceutical
A group of states, 45 members-strong, has expanded its probe into the generics pharmaceutical industry by expanding its case to …
Teva under investigation over illegal rebate offers to Ontario pharmacies
October 20, 2017Medical Communications, Sales and Marketing Teva, fentanyl, opioids, oxycodone
Israeli drugmaker Teva has again become embroiled in a scandal investigated by the Ontario government for allegedly bribing pharmacies to …
Mylan receives shock approval of Teva blockbuster
October 5, 2017Sales and Marketing Copaxone, Mylan, Teva, biotech, drugs, pharma, pharmaceutical
Mylan had been knocked back by the FDA in its quest to have its generic version of Copaxone approved earlier …
Teva completes sale of women’s health for $1.38 billion
September 19, 2017Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical, women's health
Teva announced last week that it had reached an agreement to sell Paragard, an intrauterine copper contraceptive, to CooperSurgical for …
Top Ten most popular articles on Pharmafile.com this week
September 15, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cosentyx, Eli Lilly, Martin Skreli, Teva, pharma, top ten
This week has been a particularly eventful one for the industry: among our top stories, Martin Shkreli finally heads to …
Teva announces sale of Paragard for $1.1 billion
September 12, 2017Manufacturing and Production, Sales and Marketing Paragard, Teva, biotech, drugs, pharma, pharmaceutical
Shortly after the news that Teva had finally sealed the deal on a new CEO, it also announced that it …
Teva finally announces successful CEO appointment
September 11, 2017Medical Communications, Sales and Marketing Lundbeck, Teva, biotech, drugs, pharma, pharmaceutical
Teva has announced that its protracted search for a new CEO has finally come to end, as it revealed the …
Teva scores expanded indication for Austedo in tardive dyskinesia
August 31, 2017Sales and Marketing FDA, Teva, medicine, pharma, pharmaceuticals
Following the FDA’s approval of Teva’s Austedo (deutetrabenazine) in the treatment of chorea associated with Huntington’s disease in April this …
US Congressmen accuse Teva of price hikes over 1,000%
August 21, 2017Sales and Marketing Copaxone, Teva, life sciences, medicine, multiple sclerosis, pharma, pharmaceutical, price hiking
A pair of US Congressmen have fired allegations at Israeli drugmaker Teva accusing the firm of hiking the price of …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
